P Nachtigal Selected Research

P Nachtigal Research Topics

3	Inflammation (Inflammations) 01/2021 - 06/2015
2	Atherosclerosis 08/2015 - 12/2009
2	Atherosclerotic Plaque (Atheroma) 08/2015 - 06/2015
1	Homozygous Familial Hypercholesterolemia 01/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021
1	Weight Loss (Weight Reduction) 08/2015
1	Acute-Phase Reaction 08/2015
1	Hereditary Hemorrhagic Telangiectasia 06/2015
1	Cardiotoxicity 09/2009
1	Left Ventricular Dysfunction 09/2009
1	Cryptorchidism (Undescended Testes) 10/2007
1	Body Weight (Weight, Body) 10/2007
1	Neoplasm Metastasis (Metastasis) 01/2001
1	Neoplasms (Cancer) 01/2001

3	EndoglinIBA 01/2021 - 12/2009
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2015
2	oxidized low density lipoproteinIBA 01/2021 - 08/2015
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 08/2015
2	LipidsIBA 01/2021 - 08/2015
2	CholesterolIBA 01/2021 - 08/2015
2	Cadherins (E-Cadherin)IBA 10/2007 - 01/2001
1	Apolipoproteins B (ApoB)IBA 01/2021
1	SelectinsIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 08/2015
1	HaptoglobinsIBA 08/2015
1	Matrix Metalloproteinases (MMPs)IBA 08/2015
1	Transcription Factors (Transcription Factor)IBA 08/2015
1	VLDL CholesterolIBA 08/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2015
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 06/2015
1	Daunorubicin (Cerubidine)FDA LinkGeneric 09/2009
1	AnthracyclinesIBA 09/2009
1	Troponin T (Troponin T1)IBA 09/2009
1	Dexrazoxane (Zinecard)FDA LinkGeneric 09/2009
1	Busulfan (Busulfex)FDA Link 10/2007

1	Therapeutics 01/2021
1	Blood Component Removal (Apheresis) 01/2021
1	High-Protein Low-Carbohydrate Diet (Atkins Diet) 08/2015